Entera Bio Statistics

Total Valuation

Entera Bio has a market cap or net worth of $79.48 million. The enterprise value is $68.85 million.

Market Cap	79.48M
Enterprise Value	68.85M

Important Dates

The next estimated earnings date is Friday, May 3, 2024, after market close.

Earnings Date	May 3, 2024
Ex-Dividend Date	n/a

Share Statistics

Entera Bio has 35.48 million shares outstanding. The number of shares has increased by 0.69% in one year.

Shares Outstanding	35.48M
Shares Change (YoY)	+0.69%
Shares Change (QoQ)	+2.71%
Owned by Insiders (%)	19.90%
Owned by Institutions (%)	10.47%
Float	24.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.65
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.32, with a Debt / Equity ratio of 0.04.

Current Ratio	10.32
Quick Ratio	n/a
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -101.80% and return on invested capital (ROIC) is -82.96%.

Return on Equity (ROE)	-101.80%
Return on Assets (ROA)	-83.90%
Return on Capital (ROIC)	-82.96%
Revenue Per Employee	n/a
Profits Per Employee	-$522,882
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Entera Bio has paid $29,000 in taxes.

Income Tax	29,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +160.56% in the last 52 weeks. The beta is 1.71, so Entera Bio's price volatility has been higher than the market average.

Beta (1Y)	1.71
52-Week Price Change	+160.56%
50-Day Moving Average	1.54
200-Day Moving Average	0.93
Relative Strength Index (RSI)	57.77
Average Volume (30 Days)	220,825

Short Selling Information

Short Interest	88,207
Short Previous Month	8,093
Short % of Shares Out	0.25%
Short % of Float	0.35%
Short Ratio (days to cover)	0.40

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.94M
Pretax Income	-8.86M
Net Income	-8.89M
EBITDA	-8.80M
EBIT	-8.86M
Earnings Per Share (EPS)	-$0.31

Full Income Statement

Balance Sheet

The company has $11.02 million in cash and $390,000 in debt, giving a net cash position of $10.63 million or $0.30 per share.

Cash & Cash Equivalents	11.02M
Total Debt	390,000
Net Cash	10.63M
Net Cash Per Share	$0.30
Equity / Book Value	10.39M
Book Value Per Share	0.29
Working Capital	10.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.31 million and capital expenditures -$17,000, giving a free cash flow of -$7.33 million.

Operating Cash Flow	-7.31M
Capital Expenditures	-17,000
Free Cash Flow	-7.33M
FCF Per Share	-$0.25

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Entera Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.69%
Shareholder Yield	-0.69%
Earnings Yield	-11.18%
FCF Yield	-9.22%

Analyst Forecast

The average price target for Entera Bio is $10.00, which is 346.43% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	346.43%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2